NCT04645641Unknown不适用
Evaluation of the Safety and Effectiveness of the Dexcom Glucose Monitoring (CGM)
适应症
试验速览
- 阶段
- 不适用
- 发起方
- DexCom, Inc.
- 入组人数
- 150
- 试验地点
- 8
- 主要终点
- System Performance
研究概览
简要总结
Evaluation of the Safety and Effectiveness of the Dexcom Glucose Monitoring (CGM) System
详细描述
The objective of the study is to establish performance of the Dexcom CGM System (System) in comparison to a blood glucose comparator method.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Other
- 盲法
- None
盲法说明
All systems worn will be blinded. Sensor wear locations will be pre-assigned. All sensor insertions will be performed at the clinic by study staff.
入排标准
- 年龄范围
- 2 Years 至 —(Child, Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Ages 2 or older
- •Diagnosis of Type 1 diabetes or Type 2 diabetes
- •Willing to wear the required number of Systems for the total duration of study wear
- •Willing to participate in Clinic Session(s) during study wear
排除标准
- •Presence of extensive skin changes/diseases at sensor wear site(s) that preclude wearing the sensor(s) on skin
- •Known allergy to medical-grade adhesives
- •Pregnancy
- •Hematocrit outside specification
- •≥ 18 years of age:
- •Male: 36.0%;
- •Female: 33.0%;
- •13-17 years of age: 35.0%;
- •7 years - 12 years of age: 32.0%;
- •End stage renal disease and currently managed by dialysis or anticipating initiating dialysis during the study wear period
- •Required or scheduled to have a Magnetic Resonance Imaging (MRI) scan, Computed Tomography (CT) scan, or diathermy during the study wear period
结局指标
主要结局
System Performance
时间窗: 10 days
System Performance will be characterized with respect to comparator venous plasma measurements.
次要结局
- System Related Adverse Device Effects(10 days)
研究者
研究点 (8)
Loading locations...
相似试验
已完成
不适用
Evaluation of the Safety and Effectiveness of the Dexcom Continuous Glucose Monitoring (CGM) SystemDiabetes MellitusNCT04794478DexCom, Inc.482
已完成
不适用
Effectiveness and Safety of the Dexcom™ G6 Continuous Glucose Monitoring SystemDiabetes MellitusNCT02880267DexCom, Inc.304
进行中(未招募)
不适用
Dexcom Continuous Glucose Monitoring System Use in aReal-World, Global Registry (Dexcom Global Registry)DiabetesNCT06483945DexCom, Inc.5,000
Unknown
不适用
Effectiveness and Safety of the Dexcom G6 Continuous Glucose Monitoring System in Non-Critically Ill Patients in the Inpatient SettingPatients Needing Glucose ControlNCT04879693DexCom, Inc.250
已完成
不适用
CGM Use in Poorly Controlled Youth With Type 1 DiabetesHigh Blood SugarType 1 DiabetesHypoglycemiaNCT04721145Johns Hopkins University26
